Cargando…
Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol(®) Enabled Amorphous Solid Dispersions
Abiraterone is a poorly water-soluble drug. It has a high melting point and limited solubility in organic solvents, making it difficult to formulate as an amorphous solid dispersion (ASD) with conventional technologies. KinetiSol(®) is a high-energy, fusion-based, solvent-free technology that can pr...
Autores principales: | Gala, Urvi, Miller, Dave, Williams, Robert O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238130/ https://www.ncbi.nlm.nih.gov/pubmed/32295245 http://dx.doi.org/10.3390/pharmaceutics12040357 |
Ejemplares similares
-
Pre-Processing a Polymer Blend into a Polymer Alloy by KinetiSol Enables Increased Ivacaftor Amorphous Solid Dispersion Drug Loading and Dissolution
por: Thompson, Stephen A., et al.
Publicado: (2023) -
Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing
por: Tan, Deck Khong, et al.
Publicado: (2020) -
Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution
por: Jara, Miguel O., et al.
Publicado: (2022) -
Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions
por: Monschke, Marius, et al.
Publicado: (2020) -
Nanoseeded Desupersaturation and Dissolution Tests for Elucidating Supersaturation Maintenance in Amorphous Solid Dispersions
por: Guner, Gulenay, et al.
Publicado: (2023)